ALK's Acarizax Meets Main Goal in China Allergy Trial
ALK said its Acarizax met the main goal in a late-stage allergy trial in China.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.